Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples